Skip to content

Stereotactic Body radiotherapy and pedicLE screw fixatioN During one hospital visit for patients with symptomatic unstable spinal metastases: A randomized trial (BLEND RCT)

Stereotactic Body radiotherapy and pedicLE screw fixatioN During one hospital visit for patients with symptomatic unstable spinal metastases: A randomized trial (BLEND RCT) - BLEND RCT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51812
Enrollment
92
Registered
2022-07-13
Start date
2022-11-30
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal metastases

Interventions

Same-day SBRT and surgical stabilization with or without decompression.

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Symptomatic (cervical, thoracic and/or lumbar) spinal metastases and impending spinal instability requiring radiotherapy and surgical stabilization • Histologic proof of malignancy or radiographic/clinical characteristics indicating malignancy beyond reasonable doubt • Radiographic evidence of spinal metastases • Fit for (radio)surgery • Age >18 years • Written informed consent

Exclusion criteria

Exclusion criteria: • SBRT cannot be delivered, e.g. in patients who cannot lie on the treatment table because of pain  • Surgery cannot be performed, e.g., multiple spinal metastases requiring surgical bridging of more than five vertebral levels • Prior surgery or radiotherapy to the index levels • Neurological deficits (ASIA C, B or A), or partial neurological deficits (ASIA D) with rapid progression (hours to days) • Life expectancy of less than 3 months

Design outcomes

Primary

MeasureTime frame
Physical functioning, four weeks after the start of the treatment, which is a functional scale from the EORTC QLQ-C15-PAL questionnaire.

Secondary

MeasureTime frame
Secondary goals are to compare the pain response, duration of pain relief, length of hospital stay, time to return to systemic therapy, neurological deterioration, adverse events (e.g. wound complications), quality of life and survival between intervention and control. In addition, we will study the cost-effectiveness.

Countries

Netherlands

Contacts

Public ContactR. Gal

Universitair Medisch Centrum Utrecht

r.gal@umcutrecht.nln.v.t.

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)